UHRF1BP1

mass-spec protein & survival
Survivalmass-specKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, UHRF1BP1 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated UHRF1BP1 data layer compared with 26 for mass-spec protein and 8 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher UHRF1BP1 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated UHRF1BP1 expression acts as an unfavorable survival marker, although some lineages such as UCEC and HNSC show a favorable association.

UCEC, PDAC, and HNSC are the cancer types where UHRF1BP1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
UCECOSMedianIII,IV1.0000.311.00128view →
PDACOSQuartileII,III,IV0.4000.656.00227view →
HNSCDFSTertileIV0.8900.444.00318view →
Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

UHRF1BP1–UCEC (OS)

Kaplan–Meier survival curve for UHRF1BP1 mass-spec protein-high vs -low samples in UCEC.

Open the UCEC breakdown →

Exploration